Literature DB >> 8321204

Cell cycle analysis of E2F in primary human T cells reveals novel E2F complexes and biochemically distinct forms of free E2F.

T Chittenden1, D M Livingston, J A DeCaprio.   

Abstract

The transcription factor E2F activates the expression of multiple genes involved in cell proliferation, such as c-myc and the dihydrofolate reductase gene. Regulation of E2F involves its interactions with other cellular proteins, including the retinoblastoma protein (Rb), the Rb-related protein p107, cyclin A, and cdk2. We undertook a detailed analysis of E2F DNA-binding activities and their cell cycle behavior in primary human T cells. Three E2F DNA-binding activities were identified in resting (G0) T cells with mobilities in gel shift assays distinct from those of previously defined E2F complexes. One of these activities was found to be a novel, less abundant, Rb-E2F complex. The most prominent E2F activity in resting T cells (termed complex X) was abundant in both G0 and G1 but disappeared as cells entered S phase, suggesting a possible role in negatively regulating E2F function. Complex X could be dissociated by adenovirus E1A with a requirement for an intact E1A conserved region 2. However, X failed to react with a variety of antibodies against Rb or p107, implicating the involvement of an E1A-binding protein other than Rb or p107. In addition to these novel E2F complexes, three distinct forms of unbound (free) E2F were resolved in gel shift experiments. These species showed different cell cycle kinetics. UV cross-linking experiments suggested that a distinct E2F DNA-binding protein is uniquely associated with the S-phase p107 complex and is not associated with Rb. Together, these results suggest that E2F consists of multiple, biochemically distinct DNA-binding proteins which function at different points in the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8321204      PMCID: PMC359943          DOI: 10.1128/mcb.13.7.3975-3983.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Retinoblastoma protein switches the E2F site from positive to negative element.

Authors:  S J Weintraub; C A Prater; D C Dean
Journal:  Nature       Date:  1992-07-16       Impact factor: 49.962

2.  Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene.

Authors:  P A Hamel; R M Gill; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1992-08       Impact factor: 4.272

3.  Cellular targets for transformation by the adenovirus E1A proteins.

Authors:  P Whyte; N M Williamson; E Harlow
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

4.  The adenovirus EIIA enhancer. Analysis of regulatory sequences and changes in binding activity of ATF and EIIF following adenovirus infection.

Authors:  M R Loeken; J Brady
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

5.  Identification of a cellular transcription factor involved in E1A trans-activation.

Authors:  I Kovesdi; R Reichel; J R Nevins
Journal:  Cell       Date:  1986-04-25       Impact factor: 41.582

6.  Role of an adenovirus E2 promoter binding factor in E1A-mediated coordinate gene control.

Authors:  I Kovesdi; R Reichel; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

7.  Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.

Authors:  S Chellappan; V B Kraus; B Kroger; K Munger; P M Howley; W C Phelps; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

8.  Adenovirus E1a prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor.

Authors:  M Zamanian; N B La Thangue
Journal:  EMBO J       Date:  1992-07       Impact factor: 11.598

9.  Promoter interaction of the E1A-inducible factor E2F and its potential role in the formation of a multi-component complex.

Authors:  A S Yee; R Reichel; I Kovesdi; J R Nevins
Journal:  EMBO J       Date:  1987-07       Impact factor: 11.598

10.  Interactions of the p107 and Rb proteins with E2F during the cell proliferation response.

Authors:  J K Schwarz; S H Devoto; E J Smith; S P Chellappan; L Jakoi; J R Nevins
Journal:  EMBO J       Date:  1993-03       Impact factor: 11.598

View more
  25 in total

1.  E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry.

Authors:  K Moberg; M A Starz; J A Lees
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

2.  E2F activity is regulated by cell cycle-dependent changes in subcellular localization.

Authors:  R Verona; K Moberg; S Estes; M Starz; J P Vernon; J A Lees
Journal:  Mol Cell Biol       Date:  1997-12       Impact factor: 4.272

3.  p130 is dispensable in peripheral T lymphocytes: evidence for functional compensation by p107 and pRB.

Authors:  G J Mulligan; J Wong; T Jacks
Journal:  Mol Cell Biol       Date:  1998-01       Impact factor: 4.272

4.  The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state.

Authors:  E J Smith; G Leone; J DeGregori; L Jakoi; J R Nevins
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

5.  Novel mechanisms of E2F induction by BK virus large-T antigen: requirement of both the pRb-binding and the J domains.

Authors:  K F Harris; J B Christensen; E H Radany; M J Imperiale
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

6.  Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.

Authors:  M Xu; K A Sheppard; C Y Peng; A S Yee; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

7.  Lack of functional retinoblastoma protein mediates increased resistance to antimetabolites in human sarcoma cell lines.

Authors:  W Li; J Fan; D Hochhauser; D Banerjee; Z Zielinski; A Almasan; Y Yin; R Kelly; G M Wahl; J R Bertino
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Characterization of the deoxycytidine kinase promoter in human lymphoblast cell lines.

Authors:  E H Chen; E E Johnson; S M Vetter; B S Mitchell
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity.

Authors:  H K Wong; E B Ziff
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

Review 10.  The cell cycle and the retinoblastoma protein family.

Authors:  M E Ewen
Journal:  Cancer Metastasis Rev       Date:  1994-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.